American Healthcare REIT, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated October 1, 2021, details the consummation of a merger between American Healthcare REIT, Inc. (formerly Griffin-American Healthcare REIT IV, Inc.) and Griffin-American Healthcare REIT III, Inc. (GAHR III). The report outlines the resulting corporate restructuring, the assumption of material debt obligations, amendments to governance documents, and the reinstatement of shareholder programs.
Key Financial Metrics and Debt Obligations
The filing focuses on the assumption of significant credit facilities rather than reporting period revenue or profit metrics. As of October 4, 2021, the Company's debt position includes:
- 2019 Corporate Line of Credit: Maximum principal of $480,000,000 (expandable to $850,000,000). Outstanding borrowings: $480,000,000. Matures January 25, 2022.
- 2019 Trilogy Credit Facility: Maximum principal of $360,000,000 (expandable to $500,000,000). Outstanding borrowings: $276,734,000. Matures September 5, 2023.
- 2018 Credit Facility: Aggregate borrowing capacity of $530,000,000. Outstanding borrowings: $448,900,000.
The filing does not provide specific revenue, net income, or cash flow figures for the reporting period.
Material Changes and Corporate Actions
Significant structural and operational changes occurred on October 1, 2021:
- Merger Completion: GAHR IV Operating Partnership merged into the Surviving Partnership, renamed American Healthcare REIT Holdings, LP. GAHR III merged into Merger Sub, a subsidiary of the Company.
- Debt Assumption: The Company assumed GAHR III's obligations under the 2019 Corporate Line of Credit and the 2019 Trilogy Credit Facility. A $150,000,000 revolving facility was cancelled upon merger.
- Share Repurchase Plan Amendment: The repurchase price for shares due to death or qualifying disability was changed from 100% of the price paid by the stockholder to the most recently published estimated net asset value per share.
- Bylaws Amendment: The Board amended the Bylaws to increase the threshold for calling special meetings from 10% to a majority of votes, change quorum requirements to a majority, and establish an exclusive forum for litigation in Maryland courts.
Outlook, Management Commentary, and Shareholder Programs
Management has taken steps to stabilize shareholder programs following the merger:
- DRIP Reinstatement: The Distribution Reinvestment Plan (DRIP) was reinstated effective with the October 2021 distribution. Stockholders may receive distributions in shares rather than cash.
- Share Repurchase Plan Partial Reinstatement: The plan is partially reinstated for requests due to death or qualifying disability for requests received between October 11, 2021, and November 30, 2021. Other requests are rejected.
- Distribution Authorization: The Board authorized a distribution of $0.033333333 per share for October 2021 (annualized rate of $0.40 per share), payable in November 2021.
- Executive Compensation: The Company assumed offer letters for key officers Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff, and Brian S. Peay.
Investor Verification Checklist
- Verify the total outstanding debt load of approximately $1.2 billion across three major credit facilities.
- Confirm the maturity dates of the 2019 Corporate Line of Credit (Jan 2022) and the 2019 Trilogy Facility (Sept 2023) to assess near-term refinancing needs.
- Review the amended Share Repurchase Plan to understand the new valuation method (NAV) for repurchases due to death or disability.
- Check the specific terms of the DRIP reinstatement and the deadline (Oct 16, 2021) for terminating participation for the October distribution.
- Examine the amended Bylaws regarding the new "majority" threshold for special meetings and the exclusive litigation forum in Maryland.